- Home
- AKRO vs PECO Comparison
AKRO vs PECO Comparison
Compare AKRO & PECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- PECO
- Stock Information
- Founded
- AKRO 2017
- PECO 1991
- Country
- AKRO United States
- PECO United States
- Employees
- AKRO N/A
- PECO N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- PECO Real Estate Investment Trusts
- Sector
- AKRO Health Care
- PECO Real Estate
- Exchange
- AKRO Nasdaq
- PECO Nasdaq
- Market Cap
- AKRO 3.9B
- PECO 4.6B
- IPO Year
- AKRO 2019
- PECO 2021
- Fundamental
- Price
- AKRO $50.09
- PECO $33.92
- Analyst Decision
- AKRO Strong Buy
- PECO Hold
- Analyst Count
- AKRO 7
- PECO 7
- Target Price
- AKRO $81.57
- PECO $37.33
- AVG Volume (30 Days)
- AKRO 997.3K
- PECO 995.0K
- Earning Date
- AKRO 08-08-2025
- PECO 07-24-2025
- Dividend Yield
- AKRO N/A
- PECO 3.63%
- EPS Growth
- AKRO N/A
- PECO 13.92
- EPS
- AKRO N/A
- PECO 0.55
- Revenue
- AKRO N/A
- PECO $694,639,000.00
- Revenue This Year
- AKRO N/A
- PECO $9.09
- Revenue Next Year
- AKRO N/A
- PECO $6.01
- P/E Ratio
- AKRO N/A
- PECO $61.46
- Revenue Growth
- AKRO N/A
- PECO 10.31
- 52 Week Low
- AKRO $21.34
- PECO $32.40
- 52 Week High
- AKRO $58.40
- PECO $40.12
- Technical
- Relative Strength Index (RSI)
- AKRO 49.73
- PECO 46.73
- Support Level
- AKRO $47.10
- PECO $32.84
- Resistance Level
- AKRO $53.02
- PECO $34.18
- Average True Range (ATR)
- AKRO 2.14
- PECO 0.71
- MACD
- AKRO -0.01
- PECO 0.02
- Stochastic Oscillator
- AKRO 51.97
- PECO 39.78
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About PECO Phillips Edison & Company Inc.
Phillips Edison & Co Inc is a real estate investment trust. The company also operates a third-party investment management business providing property management and advisory services to four unconsolidated institutional joint ventures, in which it has a partial ownership interests, and one private fund. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on market of expertise designed to optimize property value and consistently deliver a great shopping experience.